Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | Radiation Oncology

Fig. 4

From: The radiation- and chemo-sensitizing capacity of diclofenac can be predicted by a decreased lactate metabolism and stress response

Fig. 4

Effects of diclofenac on membrane Hsp70 expression. Plasma membrane Hsp70 expression on untreated and diclofenac treated (0.1, 0.2 mM for 48 h) LS174T (A), LoVo (B), A549 (C) and MDA-MB-231 (D) cancer cells. Data present the proportion of positively stained cells of at least 3 independent experiments. (E) Representative gating strategy to determine membrane Hsp70 expression on viable tumor cells. Left, side scatter (SSC)/forward scatter (FSC) dot plot histogram to identify the tumor cell population based on size (FSC) and granularity (SSC); middle, gating of Propidium Iodide (PI) negative, viable tumor cells (96.0%); right, overlay of two histograms representing membrane Hsp70 positive tumor cells (43.1%) using cmHsp70.1-FITC monoclonal antibody (mAb, gray) and the negative control (white histogram) using an isotype-matched mAb (anti-mouse IgG1-FITC). The one way ANOVA test was used to evaluate significant differences (*p ≤ 0.05, **p ≤ 0.01)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us